Researchers at the University of New Hampshire have uncovered a promising lead in diabetes treatment: venom from the cone snail (Conus geographus). This natural compound could lead to therapies that lower blood sugar faster than traditional insulin.
Diabetes remains a focal point of scientific inquiry. For instance, a 2020 French study identified a DNA mutation enabling more precise management of type 2 diabetes. Building on this, a study published October 18, 2021, in the journal Proteins by University of New Hampshire researchers highlights a natural remedy from the cone geographer snail (Conus geographus).
This snail's venom induces a paralyzing hypoglycemic shock in prey, dropping blood sugar levels more rapidly than insulin. While insulin therapy—alongside leptin studies—remains a cornerstone treatment, effective alternatives are scarce.
Unlike human insulin, the snail venom's peptide sequence is shorter yet binds effectively to human insulin receptors, suggesting potential for superior diabetes drugs.
The team analyzed insulin-like peptide sequences from the venom, modeling six analog complexes to assess binding to human insulin receptors. Results show the snail's insulin binds more efficiently despite its shorter structure.
"While further studies are needed, our research shows that, despite the shorter peptide sequences, cone snail venom may be a viable substitute for insulin and we hope it will drive the design of new fast-acting drugs," said Biswajit Gorai, lead author of the study. This breakthrough opens doors to novel blood sugar stabilization treatments.
With diabetes cases rising globally and few viable alternatives, this research is a timely advancement.
